It was agreed, — That the proposed budget in the amount of $7,250, for the briefing with the Canadian Centre on Substance Use and Addiction, be adopted.

It was agreed, — That the proposed budget in the amount of $14,500, for the study of Bill C-224, An Act to amend the Food and Drugs Act (natural health products), be adopted.

Dan Mazier moved, — That the committee order the production of the following complete and fully unredacted documents:

a) the audit conducted by MNP that assessed the design of the financial controls framework for the Canadian Dental Care Plan;

b) all briefing notes, recommendations, and documents provided to the Minister of Health or the Minister’s Office regarding the October 17, 2025 change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

c) the number of Canadian Dental Care Plan patients who received prior authorization for treatments involving laboratory fees before October 17, 2025 but received reduced reimbursement after that date;

d) all correspondence between Health Canada and Sun Life Financial regarding the change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan

e) all analysis conducted on the impact the Canadians Dental Care Plan will have to dental schools in Canada;

f) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes, from for the Substance Use and Addictions Program since 2020 as requested by the committee on December 9, 2025;

g) all applications and corresponding signed agreements, except with Quebec, including appendices and annexes from for the Emergency Treatment Fund since 2020 as requested by the committee on December 9, 2025;

h) all applications received by the government to administer the Vaccine Injury Support Program, including all recommendation documents provided to the Minister’s Office on the applicants;

i) all documents related to PrescribeIT, including: the 2017 contract between Canada Health Infoway and TELUS Health; all amendments, renewals, and change orders since 2017; all intellectual property ownership agreements; the 2026 termination notice and all clauses, provisions, or records relating to termination and penalties; a list of all payments made by Canada Health Infoway to TELUS Health since 2017; and all recommendation documents provided to the Minister’s Office regarding PrescribeIT funding, operations, and termination;

j) all agreements between Canadian Blood Services and Grifols related to the manufacture, processing, or supply of both blood and plasma-derived products, including all amendments and related agreements;

k) all quarterly reports and underlying data submitted to Health Canada’s Office of Controlled Substances by provincial or territorial Ministers of Health, except from Quebec, pursuant to the subsection 56(1) class exemption for Urgent Public Health Need Sites;

At 5:11 p.m., the meeting was suspended.

At 5:24 p.m., the meeting resumed.

Debate arose thereon.

At 5:55 p.m., the meeting was suspended.

At 6:16 p.m., the meeting resumed.

The debate continued on the amendment of Sonia Sidhu.

At 6:25 p.m., the meeting was suspended.

At 6:49 p.m., the meeting resumed.

The debate continued on the subamendment of Dan Mazier.

The debate continued on the amendment of Sonia Sidhu as amended.

The debate continued on the motion of Dan Mazier as amended.

The debate resumed on the motion as amended.

After debate, the question was put on the motion, as amended, and it was agreed to.

The motion, as amended, read as follows:

That the committee order the production of the following complete and fully unredacted documents:

a) the audit conducted by MNP that assessed the design of the financial controls framework for the Canadian Dental Care Plan;

b) all briefing notes, recommendations, and documents provided to the Minister of Health or the Minister’s Office regarding the October 17, 2025 change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

c) the number of Canadian Dental Care Plan patients who received prior authorization for treatments involving laboratory fees before October 17, 2025 but received reduced reimbursement after that date;

d) all correspondence between Health Canada and Sun Life Financial regarding the change to reimbursement criteria for laboratory fees under the Canadian Dental Care Plan;

e) all analysis conducted on the impact the Canadians Dental Care Plan will have to dental schools in Canada;

f) all applications and corresponding signed agreements, including appendices and annexes, from for the Substance Use and Addictions Program since 2020 as requested by the committee on December 9, 2025;

g) all applications and corresponding signed agreements, including appendices and annexes from for the Emergency Treatment Fund since 2020 as requested by the committee on December 9, 2025;

h) all applications received by the government to administer the Vaccine Injury Support Program, including all recommendation documents provided to the Minister’s Office on the applicants;

i) all documents related to PrescribeIT, and all recommendation documents provided to the Minister’s Office regarding PrescribeIT funding, operations, and termination; and that one three-hour meeting be held no later than April 24, 2026, with one hour each dedicated to 1) TELUS, 2) Canada Health Infoway, and 3) government officials, in that respective order, for testimony on PrescribeIT;

j) all agreements between Canadian Blood Services and Grifols related to the manufacture, processing, or supply of both blood and plasma-derived products, including all amendments and related agreements;

k) all quarterly reports and underlying data submitted to Health Canada’s Office of Controlled Substances by provincial or territorial Ministers of Health, pursuant to the subsection 56(1) class exemption for Urgent Public Health Need Sites.

By unanimous consent, on motion of Matt Strauss, it was agreed, — That the Chair request both 1) Health Canada and 2) Manitoba Chief Medical Examiner to provide the Committee with the final reports and findings of the investigation(s) into the recent deaths of two individuals at Grifols plasma collection centres in Winnipeg, Manitoba; and be provided within 14 days of the adoption of this motion.

On motion of Maggie Chi, it was agreed, — That the committee do now adjourn.